Date:
Fireside
2023
Date:
Location:
In-person 1x1 investor meetings only
About
Investor Inquiries
ICR Westwicke
339.970.2843
chris.brinzey@westwicke.com
Media Inquiries
917.548.1582
media@replimune.com
![](https://ml.globenewswire.com/media/NmQwMDIyOTktZjZkYS00ZjU4LWE3MGEtM2YxNDMxYTNmNjExLTExMjIxMDE=/tiny/Replimune-Group-Inc.png)
2023 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.71 USD | -1.25% |
|
+14.01% | +3.32% |
06-24 | Replimune Group, Inc.(NasdaqGS:REPL) dropped from S&P Biotechnology Select Industry Index | CI |
06-13 | Replimune Group Signs $100 Million PIPE Deal with Institutional Investors | MT |
Date:
Fireside
2023
Date:
Location:
In-person 1x1 investor meetings only
About
Investor Inquiries
ICR Westwicke
339.970.2843
chris.brinzey@westwicke.com
Media Inquiries
917.548.1582
media@replimune.com
2023 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
+3.32% | 535M | |
+23.13% | 46.93B | |
+37.74% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+45.05% | 14.15B | |
+32.23% | 12.53B | |
-6.56% | 11.36B |